Skip to main content
SpringerLink
Log in
Book cover

Hepatology Principles and Practice pp 541–562Cite as

Drug-induced liver damage

  • Chapter

  • 1550 Accesses

Keywords

  • Liver Damage
  • Acute Liver Failure
  • Herbal Remedy
  • Focal Nodular Hyperplasia
  • Fulminant Hepatic Failure

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aithal, P.G., Day, C.P.: The natural history of histologically proved drug-induced liver disease. Gut 1999; 44: 731–735

    CAS  PubMed  Google Scholar 

  2. Al Sarraf, K.A.A., Michielsen, P.P., Hauben, E.I., Lefebure, A., Ramon, A.M., van Marck, E.A., Pelckmans, P.A.: Hepatotoxicity after a short course of low-dose pyrazinamide. Acta Gastro-Enterol. Belg. 1996; 59: 251–253

    Google Scholar 

  3. Amaro, P., Nunes, A., Macoas, F., Ministro, P., Baranda, J., Cipriano, A., Martins, I., Rosa, A., Pimenta, I., Donato, A., Freitas, D.: Ticlopidine-induced prolonged cholestasis: a case report. Eur. J. Gastroenterol. Hepatol. 1999; 11: 673–676

    CAS  PubMed  Google Scholar 

  4. Andrade, R.J., Lucena, M.I., Fernandez, M.C., Vega, J.L., Garcia-Cortes, M., Casado, M., Guerrero-Sanchez, E., Pulido-Fernandez, F.: Cholestatic hepatitis related to use of irbesartan: a case report and a literature review of antiotensin II antagonist-associated hepatotoxicity. Eur. J. Gastroenterol. Hepatol. 2002; 14: 887–890

    CrossRef  PubMed  Google Scholar 

  5. Andrade, R.J., Lucena, M.I., Martin-Vivaldi, R., Fernandez, M.C., Nogueras, F., Pelaez, G., Gomez-Outes, A., Garcia-Escano, M.D., Bellot, V., Hervas, A., Cardenas, F., Bermudez, F., Romero, M., Salmeron, J.: Acute liver injury associated with the use of ebrotidine, a new H-2 receptor antagonist. J. Hepatol. 1999; 31: 641–646

    CrossRef  CAS  PubMed  Google Scholar 

  6. Andreu, V., Mas, A., Bruguera, M., Salmeron, J.M., Moreno, V., Nogue, S., Rodes, J.: Ecstasy: a common cause of severe acute hepatotoxicity. J. Hepatol. 1998; 29: 394–397

    CrossRef  CAS  PubMed  Google Scholar 

  7. Barrio, J., Castiella, A., Lobo, C., Indart, A., Lopez, P., Garcia-Bengoechea, M., Cosme, A., Arenas, J.I.: Hepatitis colestasica aguda secundaria a amoxicillina-acido clavulanico. Papel del acido ursodesoxicolico en la colestasis inducida por drogas. Rev. Esp. Enferm. Dig. 1998; 90: 523–526

    CAS  PubMed  Google Scholar 

  8. Basset, C., Vadrot, J., Denis, J., Poupon, J., Zafrani, E.S.: Prolonged cholestasis and ductopenia following gold salt therapy (case report). Liver Internat. 2003; 23: 89–93

    Google Scholar 

  9. Berson, A., Fréneaux, E., Larrey, D., Lepage, V., Douay, C., Mallet, C., Fromenty, B., Benhamou, J.-P., Pessayre, D.: Possible role of HLA in hepatotoxicity. An exploratory study in 71 patients with drug-induced idiosyncratic hepatitis. J. Hepatol. 1994; 20: 336–342

    CrossRef  CAS  PubMed  Google Scholar 

  10. Borges, N.: Tolcapone-related liver dysfunction. Implications for use in Parkinsonπs disease therapy. Drug Saf. 2003; 226: 743–747

    Google Scholar 

  11. Böttiger, L.E., Furhoff, A.K., Holmberg, L.: Fatal reactions to drugs. A 10-year material from the Swedish Adverse Drug Reaction Committee. Acta Med. Scand. 1979; 205: 451–456

    PubMed  Google Scholar 

  12. Braun, M., Fraser, G.M., Kunin, M., Salamon, F., Kaspa, R.T.: Mesalamine-induced granulomatous hepatitis. Amer. J. Gastroenterol. 1999; 94: 1973–1974

    CAS  Google Scholar 

  13. Cadranel, J.-F., Cadranel, J., Buffet, C., Fabre, M., Pelletier, G., d’Agay, M.-F., Ink, O., Roche, A., Milleron, B., Etienne, J.-P.: Nodular regenerative hyperplasia of the liver, peliosis hepatis, and perisinusoidal fibrosis. Gastroenterology 1990; 99: 268–273

    CAS  PubMed  Google Scholar 

  14. Carrascosa, M., Pascual, F., Aresti, S.: Acarbose-induced acute severe hepatotoxicity. Lancet 1997; 349: 698–699

    CrossRef  CAS  PubMed  Google Scholar 

  15. Castedal, M., Aldenborg, F., Olsson, R.: Fulminant hepatic failure associated with dicoumarol therapy. Liver 1998; 18: 67–69

    CAS  PubMed  Google Scholar 

  16. Ceriani, R., Borroni, G., Bissoli, F.: Ritodrine-related liver injury. Case report and review of the literature. Ital. J. Gastroenterol. Hepatol. 1998; 30: 315–317

    CAS  PubMed  Google Scholar 

  17. Chandrupatla, S., Demetris, A.J., Rabinovitz, M.: Azithromycininduced intrahepatic cholestasis (case report). Dis. Dis. Sci. 2002; 47: 2186–2188

    Google Scholar 

  18. Chariot, P., Drogou, I., de Lacroix-Szmania, I., Eliezer-Vanerot, M.C., Chazaud, B., Lombès, A., Schaeffer, A., Zafrani, E.S.: Zidovudineinduced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion. J. Hepatol. 1999; 30: 156–160

    CrossRef  CAS  PubMed  Google Scholar 

  19. Chitturi, S., Le, V., Kench, J., Loh, C., George, J.: Gliclazide-induced acute hepatitis with hypersensitivity features. Dig. Dis. Sci. 2002; 47: 1107–1110

    CrossRef  PubMed  Google Scholar 

  20. Cicognani, C., Malavolti, M., Morselli-Labate, A.M., Sama, C., Barbara, L.: Flutamide-induced toxic hepatitis. Potential utility of ursodeoxycholic acid administration in toxic hepatitis. Dig. Dis. Sci. 1996; 41: 2219–2221

    CrossRef  CAS  PubMed  Google Scholar 

  21. Closa, A.S., Rovira, E.C., Lopez, J.V.A., Gispert, J.S.: Necrosis hepatica submassiva asociada a tratamiento con salos de oro. Gastroenterol. Hepatol. 1983; 6: 468–470

    Google Scholar 

  22. Cocozella, D., Curciarello, J., Corallini, O., Olivera, A., Alburquerque, M.M., Fraquelli, E., Zamagna, L., Olenchuck, A., Cremona, A.: Propafenone hepatotoxicity — report of two new cases. Dig. Dis. Sci. 2003; 48: 354–357

    Google Scholar 

  23. Daifotis, A.G., Yates, A.J.: Liver damage due to alendronate. New Engl. J. Med. 2000; 343: 365–366

    Google Scholar 

  24. De Bruyne, E.L.E., Bac, D.J., de Man, R.A., Dees, A.: Jaundice associated with acenocoumarol exposure. Neth. J. Med. 1998; 52: 187–189

    PubMed  Google Scholar 

  25. Dhawan, M., Agrawal, R., Ravi, J., Gulati, S., Silverman, J., Nathan, G., Raab, S., Brodmerkel, G.: Rosiglitazone-induced granulomatous hepatitis (case report). J. Clin. Gastroenterol. 2002; 34: 582–584

    CrossRef  PubMed  Google Scholar 

  26. Dourakis, S.P., Papanikolaou, I.S., Tzemanakis, E.N., Hadziyannis, S.J.: Acute hepatitis associated with herb (Teucrium capitatum L. ) administration (case report). Eur. J. Gastroenterol. Hepatol. 14: 693–695

    Google Scholar 

  27. Durazo, F.A., Lassman, C., Han, S.H.B., Saab, S., Lee, N.P., Kawano, M., Saggi, B., Gordon, S., Farmer, D.G., Yersiz, H., Goldstein, R.L.I., Ghobrial, M., Busuttil, R.W.: Fulminant liver failure dueto usnic acid for weight loss (case report). Amer. J. Gastroenterol. 2004; 99: 950–952

    Google Scholar 

  28. Erpecum, van, K.J., Janssens, A.R., Ruiter, D.J., Kroon, H.M.J.A., Grond, A.J.K.: Generalized peliosis hepatis and cirrhosis after longterm use of oral contraceptives. J. Amer. Gastroenterol. 1988; 83: 572–575

    Google Scholar 

  29. Farrell, G., Prendergast, D., Murray, M.: Halothane hepatitis. Detection of a constitutional susceptibility factor. New Engl. J. Med. 1985; 313: 1310–1314

    CAS  PubMed  Google Scholar 

  30. Fong, D.G., Angulo, P., Burgart, L.J., Lindor, K.D.: Cetirizine-induced cholestasis. J. Clin. Gastroenterol. 2000; 31: 250–253

    CrossRef  CAS  PubMed  Google Scholar 

  31. Forbes, G.M., Jeffrey, G.P., Shilkin, K.B., Reed, W.D.: Carbamazepine hepatotoxicity: another cause of vanishing bile duct syndrome. Gastroenterology 1992; 102: 1385–1388

    CAS  PubMed  Google Scholar 

  32. Friis, H., Andreasen, P.B.: Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish Committee on Adverse Drug Reactions between 1978 and 1987. J. Intern. Med. 1992; 232: 133–138

    CAS  PubMed  Google Scholar 

  33. Ganne-Carié, N., de Leusse, A., Guettier, C., Castera, L., Levecq, H., Bertrand, H.-J., Plumet, Y., Trinchet, J.-C., Beaugrand, M.: Hépatites d’allure auto-immune induites par les fibrates. Gastroenterol. Clin. Biol. 1998; 22: 525–529

    Google Scholar 

  34. Goland, S., Malnick, St., D.H., Gratz, R., Feldberg, E., Geltner, D., Sthoeger, Z.M.: Severe cholestatic hepatitis following cloxacillin treatment. Postgrad. Med. J. 1998; 74: 59–60

    CAS  PubMed  Google Scholar 

  35. Gordon, D.F., Rosenthal, G., Hart, J., Sirota, R., Baker, A.L.: Chaparral ingestion: the broadening spectrum of liver injury caused by herbal medications. J. Amer. Med. Ass. 1995; 273: 489–490

    CAS  Google Scholar 

  36. Graham, D.J., Green, L., Senior, J.R., Nourjah, P.: Troglitazone-induced liver failure: a case study. Amer. J. Med. 2003; 114: 299–306

    PubMed  Google Scholar 

  37. Gresser, U.: Amoxicillin-clavulanic acid therapy may be associated with severe side effects-review of the literature. Eur. J. Med. Res. 2001; 6: 139–149

    CAS  PubMed  Google Scholar 

  38. Grieco, A., Vecchio, F.M., Greco, A.V., Gasbarrini, G.: Cholestatic hepatitis due to ticlopidine: clinical and histological recovery after drug withdrawal. Case report and review of the literature. Europ. J. Gastroenterol. Hepatol. 1998; 10: 713–715

    CAS  Google Scholar 

  39. Gut, J., Christen, U., Huwyler, J.: Mechanisms of halothane toxicity: novel insights. Pharmacol. Ther. 1993; 58: 133–155

    CrossRef  CAS  PubMed  Google Scholar 

  40. Habscheid, W., Abele, U., Dahm, H.H.: Anabolic steroids as a cause of severe cholestasis and renal failure in a bodybuilder. Dtsch. Med. Wschr. 1999; 124: 1029–1032

    CAS  PubMed  Google Scholar 

  41. Hackstein, H., Mohl, W., Püschel, W., Stallmach, A., Zeitz, M.: Acute cholestatic hepatitis associated with diclofenac. Z. Gastroenterol. 1998; 36: 385–389

    CAS  PubMed  Google Scholar 

  42. Hanger, F.M., Gutman, A.B.: Post-arsphenamine jaundice. Apparently due to obstruction of intrahepatic biliary tract. J. Amer. Med. Ass. 1940; 115: 263–271

    Google Scholar 

  43. Hartleb, M., Rymarczyk, G., Januszewski, K.: Acute cholestatic hepatitis associated with pravastatin. Amer. J. Gastroenterol. 1999; 94: 1388–1390

    CAS  Google Scholar 

  44. Helling, T.S., Wood, W.G.: Oral contraceptives and cancer of the liver: a review with two additional cases. Amer. J. Gastroenterol. 1982; 77: 504–508

    CAS  Google Scholar 

  45. Henry, J.A., Jeffreys, K.J., Dawling, S.: Toxicity and deaths from 3,4-methylenedioxymethamphetamine (“ecstasy”). Lancet 1992; 340: 384–387

    CrossRef  CAS  PubMed  Google Scholar 

  46. Homberg, J.C., Stelly, N., Andreis, I., Abuaf, N., Saadoun, F.: A new antimitochondrial antibody (anti-M6) in iproniazid-induced hepatitis. Clin. Exp. Immunol. 1982; 47: 93–102

    CAS  PubMed  Google Scholar 

  47. Hui, C.K., Yuen, M.F., Wong, W.M., Lam, S.K., Lai, C.L.: Mirtazapine-induced hepatotoxicity (case report). J. Clin. Gastroenterol. 2002; 35: 270–271

    CrossRef  CAS  PubMed  Google Scholar 

  48. Hunter, E.B., Johnston, P.E., Tanner, G., Pinson, C.W., Awad, J.A.: Bromfenac (Duract)-associated hepatic failure requiring liver transplantation. Amer. J. Gastroenterol. 1999; 94: 2299–2301

    CAS  Google Scholar 

  49. Ibanez, L., Perez, E., Vidal, X., Laporte, J.-R.: Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic disease: epidemiological and clinical features, and exposure to drugs. J. Hepatol. 2002; 37: 572–580

    Google Scholar 

  50. Ichiki, Y., Akahoshi, M., Yamashita, N., Morita, C., Maruyama, T., Horiuchi, T., Hayashida, K., Ishibashi, H., Niho, Y.: Propylthiouracil-induced severe hepatitis: A case report and review of the literature. J. Gastroenterol. 1998; 33: 747–750

    CrossRef  CAS  PubMed  Google Scholar 

  51. James, L.P., Mayeux, P.R., Hinson, J.A.: Acetaminophen-induced hepatotoxicity. Drug Metab. Disp. 2003; 31: 1499–1506

    CAS  Google Scholar 

  52. Kanda, T., Yokosuka, O., Fujiwara, K., Saisho, H., Shiga, H., Oda, S., Okuda, K., Sugawara, Y., Makuuchi, M., Hirasawa, H.: Fulminant hepatic failure associated with triazolam. Dig. Dis. Sci. 2002; 47: 1111–1114

    CrossRef  PubMed  Google Scholar 

  53. Kaplowitz, N.: Hepatotoxicity of herbal remedies: insights into the intricacies of plant-animal warfare and cell death. Gastroenterology 1997; 113: 1408–1412

    CrossRef  CAS  PubMed  Google Scholar 

  54. Kaplowitz, N.: Biochemical and cellular mechanisms of toxic liver injury. Semin. Liver Dis. 2002; 22: 137–144

    CrossRef  CAS  PubMed  Google Scholar 

  55. Katsinelos, P., Katsos, I., Patsiaoura, K., Xiarchos, P., Goulis, I., Eugenidis, N.: Tenoxicam-associated hepatic injury: a case report and review. Europ. J. Gastroenterol. Hepatol. 1997; 9: 403–406

    CAS  Google Scholar 

  56. Katz, M., Saibil, F.: Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf. J. Clin. Gastroenterol. 1990; 12: 203–206

    CAS  PubMed  Google Scholar 

  57. Knobel, B., Buyanowsky, G., Dan, M., Zaidel, L.: Pyrazinamideinduced granulomatous hepatitis. J. Clin. Gastroenterol. 1997; 24: 264–266

    CrossRef  CAS  PubMed  Google Scholar 

  58. Köksal, A.S., Köklü, S., Filik, L., Sasmaz, N., Sahin, B.: Phenyramidolassociated liver toxicity. Ann. Pharmacol. 2003; 37: 1244–1246

    Google Scholar 

  59. Kuntz, E., Liehr, H., Pfingst, W.: Toxische Leberschäden durch Äthionamid. Dtsch. Med. Wschr. 1967; 92: 1718–1722

    CAS  PubMed  Google Scholar 

  60. Kuntz, E., Ordnung, W., Schmidt, U., Wildhirt, E., Engels, Ch.: Leber und Umwelt. Eine anamnestische Praxisstudie. Kassenarzt 1988; 7: 32–40

    Google Scholar 

  61. Kuntz, E.: Lebererkrankungen aus der Sicht der niedergelassenen Ärzte. (Befragung von 2990 Ärzten). Notabene medici 1989; 19: 243–246

    Google Scholar 

  62. Kuntz, H.-D., Rausch, V.: Hepatotoxische Nebenwirkungen von Rifampicin — eine vergleichende Studie. Prax. Pneumol. 1977; 31: 925–932

    CAS  Google Scholar 

  63. Labowitz, J.K., Silverman, W.B.: Cholestatic jaundice induced by ciprofloxacin. Dig. Dis. Sci. 1997; 42: 192–194

    CrossRef  CAS  PubMed  Google Scholar 

  64. Lammert, F., Matern, S.: Hepatopathien durch Medikamente. Schweiz. Rundsch. Med. 1997; 86: 1167–1171

    CAS  Google Scholar 

  65. Larrey, D., Pageaux, G.P.: Genetic predisposition to drug-induced hepatotoxicity. J. Hepatol. 1997; 26: 12–21

    CAS  PubMed  Google Scholar 

  66. Lauterburg, B.H.: Arzneimittelschäden der Leber: Rolle von reaktiven Metaboliten und Pharmakokinetik. Schweiz. Med. Wschr. 1985; 115: 1306–1312

    CAS  PubMed  Google Scholar 

  67. Leone, N., Giordanino, C., Baronio, M., Morgando, A., David, E., Rizzetto, M.: Ticlopidine-induced cholestatic hepatitis successfully treated with corticosteroids: A case report. Hepatol. Res. 2004; 28: 109–112

    CAS  Google Scholar 

  68. Lewis, J.H., Mullick, F., Ishak, K.G., Ranard, R.C., Ragsdale, B., Perse, R.M., Rusnock, E.J., Wolke, A., Benjamin, S.B., Seeff, L.B., Zimmerman, H.J.: Histopathologic analysis of suspected amiodarone hepatotoxicity. Hum. Pathol. 1990; 21: 59–67

    CrossRef  CAS  PubMed  Google Scholar 

  69. Lown, K.S.: Drug-induced liver disease. Curr. Opin. Gastroenterol. 1998; 14: 208–214

    Google Scholar 

  70. Ludwig, J., Axelsen, R.: Drug effects on the liver. An updated tabular compilation of drugs and drug-related hepatic diseases. Dig. Dis. Sci. 1983; 28: 651–666

    CrossRef  CAS  PubMed  Google Scholar 

  71. Macfarlane, B., Davies, S., Mannan, K., Sarsam, R., Pariente, D., Dooley, J.: Fatal acute fulminant liver failure due to clozapine: a case report and review of clozapine-induced hepatotoxicity. Gastroenterology 1997; 112: 1707–1709

    CrossRef  CAS  PubMed  Google Scholar 

  72. MacGregor, F.B., Abernethy, V.E., Dahabra, S., Cobden, I., Hayes, P.C.: Hepatotoxicity of herbal remedies. Brit. Med. J. 1989; 299: 1156–1157

    CAS  PubMed  Google Scholar 

  73. Mayoral, W., Lewis, J.H.: Drug-induced liver disease. Curr. Opin. Gastroenterol. 2000; 16: 231–238

    CrossRef  CAS  Google Scholar 

  74. McCormick, P.A., Kennedy, F., Curry, M., Taylor, O.: Cox 2 inhibitor and fulminant hepatic failure. Lancet 1999; 353: 40–41

    CrossRef  CAS  PubMed  Google Scholar 

  75. McCormick, P.A., Treanor, D., McCormack, G., Farrell, M.: Early death from paracetamol (acetaminophen) induced fulminant hepatic failure without cerebral oedema. J. Hepatol. 2003; 39: 547–551

    CrossRef  CAS  PubMed  Google Scholar 

  76. McRae, C.A., Agarwal, K., Mutimer, D., Bassendine, M.F.: Hepatitis associated with Chinese herbs. Eur. J. Gastroenterol. Hepatol. 2002; 14: 559–562

    CrossRef  CAS  PubMed  Google Scholar 

  77. Meissner, K.: Hemorrhage caused by ruptured liver cell adenoma following long-term oral contraceptives; a case report. Hepato-Gastroenterol. 1998; 45: 224–225

    CAS  Google Scholar 

  78. Meyer, M.I., Kuhn, M., Bühler, H., Bertschinger, P.: Ticlopidine-induced cholestasis. Schweiz. Med. Wschr. 1999; 129: 1405–1409

    CAS  PubMed  Google Scholar 

  79. Minoda, Y., Kharasch, E.D.: Halothane-dependent lipid peroxidation in human liver microsomes is catalized by cytochrome P 450 2A6 (CYP 2A6). Anesthesiology 2001; 95: 509–514

    CAS  PubMed  Google Scholar 

  80. Mix, H., Wagner, S., Böker, K., Gloger, S., Oldhafer, K.J., Behrend, M., Flemming, P., Manns, M.P.: Subacute liver failure induced by phenprocoumon treatment. Digestion 1999; 60: 579–582

    CrossRef  CAS  PubMed  Google Scholar 

  81. Moitinho, E., Salmeron, J.M., Mas, A., Bruguera, M., Rodes, J.: Hepatotoxicidad grave por tuberculostaticos. Incremento de la incidencia. Gastroenterol. Hepatol. 1996; 19: 448–451

    CAS  PubMed  Google Scholar 

  82. Montessori, V., Harris, M., Montaner, J.S.G.: Hepatotoxicity of nucleoside reverse transcriptase inhibitors. Semin. Liver Dis. 2003; 23: 167–171

    CAS  PubMed  Google Scholar 

  83. Moses, P.L., Schroeder, B., Alkhatib, O., Ferrentino, N., Suppan, T., Lidofsky, S.D.: Severe hepatotoxicity associated with bromfenac sodium. Amer. J. Gastroenterol. 1999; 94: 1393–1396

    CAS  Google Scholar 

  84. Novak, D., Lewis, J.H.: Drug-induced liver disease. Curr. Opin. Gastroenterol. 2003; 19: 203–215

    CrossRef  CAS  PubMed  Google Scholar 

  85. O’Connor, N., Dargan, P.I., Jones, A.L.: Hepatocellular damage from non-steroidal anti-inflammatory drugs. Quart. M. Med. 2003; 96: 787–791

    CAS  Google Scholar 

  86. Palmer, J.R., Rosenberg, L., Kaufman, D.W., Warshauer, M.E., Stolley, P., Shapiro, S.: Oral contraceptive use and liver cancer. Amer. J. Epidemiol. 1989; 130: 878–882

    CAS  Google Scholar 

  87. Persky, S., Reinus, J.F.: Sertraline hepatotoxicity — a case report and review of the literature on selective serotonin reuptake inhibitor hepatotoxicity (case report). Dis. Dis. Sci. 2003; 48: 939–944

    CAS  Google Scholar 

  88. Pessayre, D.: Role of reactive metabolites in drug-induced hepatitis. J. Hepatol. 1995; 23(Suppl. 1) 16–24

    CAS  PubMed  Google Scholar 

  89. Picciotto, A., Campo, N., Brizzolara, R., Giusto, R., Guido, G., Sinelli, N., Lapertosa, G., Celle, G.: Chronic hepatitis induced by Jin Bu Huan. J. Hepatol. 1998; 28: 165–167

    CrossRef  CAS  PubMed  Google Scholar 

  90. Pittler, M.H., Ernst, E.: Systematic review: Hepatotoxic events associated with herbal medicinal products. Alim. Pharm. Ther. 2003; 18: 451–471

    CAS  Google Scholar 

  91. Polymeros, D., Kamberoglou, D., Tzias, V.: Acute cholestatic hepatitis caused by Teucrium polium (Golden germander) with transient appearance of antimitochondrial antibody. J. Clin. Gastroenterol. 2002; 34: 100–101

    CrossRef  PubMed  Google Scholar 

  92. Pontiroli, L., Sartori, M., Pittau, S., Morelli, S., Boldorini, R., Albano, E.: Flutamide-induced acute hepatitis: investigations on the role of immunoallergic mechanisms. Ital. J. Gastroenterol. Hepatol. 1998; 30: 310–314

    CAS  PubMed  Google Scholar 

  93. Richardet, J.P., Mallat, A., Zafrani, E.S., Blazquez, M., Bognel, J.C., Campillo, B.: Prolonged cholestasis with ductopenia after administration of amoxicillin/clavulanic acid. Dig. Dis. Sci. 1999; 44: 1997–2000

    CrossRef  CAS  PubMed  Google Scholar 

  94. Robinson, K., Lambiase, L., Li, J.J., Monteiro, C., Schiff, M.: Fatal cholestatic liver failure associated with gemcitabine therapy (case report). Dig. Dis. Sci. 2003; 48: 1804–1808

    CrossRef  PubMed  Google Scholar 

  95. Romagnuolo, J., Sadowski, D.C., Lalor, E., Jewell, L., Thomson, A.B.R.: Cholestatic hepatocellular injury with azathioprine: A case report and review of the mechanisms of hepatotoxicity. Can. J. Gastroenterol. 1998; 12: 479–483

    CAS  PubMed  Google Scholar 

  96. Roots, I.: Genetische Ursachen für die Variabilität der Wirkungen und Nebenwirkungen von Arzneimitteln. Internist 1982; 23: 601–609

    CAS  PubMed  Google Scholar 

  97. Roques, V., Perney, P., Beaufort, P., Hanslick, B., Ramos, J., Durand, L., Le Bricquir, Y., Blanc, F.: Hépatite aigué à l’ecstasy. Presse Med. 1998; 27: 468–470

    CAS  PubMed  Google Scholar 

  98. Ruiz, J.K., Rossi, G.V., Vallejos, H.A., Brenet, R.W., Lopez, I.B., Escribano, A.A.: Fulminant hepatic failure associated with propylthiouracil. Ann. Pharmacother. 2003; 37: 224–228

    CrossRef  PubMed  Google Scholar 

  99. Russmann, S., Barguil, Y., Cabalion, P., Kritsanida, M., Duhet, D., Lauterburg, B.H.: Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia (case report). Eur. J. Gastroenterol. 2003; 15: 1033–1036

    Google Scholar 

  100. Sahai, A., Villeneuve, J.: Terfenadine-induced cholestatic hepatitis. Lancet 1996; 348: 552–553

    CrossRef  CAS  PubMed  Google Scholar 

  101. Sahoo, S., Hart, J.: Histopathological features of L-asparaginase-induced liver disease. Semin. Liver Dis. 2003; 23: 295–299

    PubMed  Google Scholar 

  102. Seidl, C., Thomsen, R., Lohse, A., Grouls, V.: Phenprocoumon-associated hepatitis. A rare complication of oral anticoagulation. Leber Magen Darm 1998; 28: 178–182

    Google Scholar 

  103. Selim, K., Kaplowitz, N.: Hepatotoxicity of psychotropic drugs. Hepatology 1999; 29: 1347–1351

    CrossRef  CAS  PubMed  Google Scholar 

  104. Sevilla-Mantilla, C., Ortega, L., Agundez, J.A.G., Fernandez-Gutierrez, B., Ladero, J.M., Diaz-Rubio, M.: Leflunomide-induced acute hepatitis. Dis. Dis. 2004; 36: 82–84

    CAS  Google Scholar 

  105. Sgro, C., Clinard, F., Ouazir, K., Chanay, H., Allard, C., Guilleminet, C., Lenoir, C., Lemoine, A., Hillon, P.: Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 2002; 36: 451–455

    CrossRef  PubMed  Google Scholar 

  106. Sheikh, N.M., Philen, R.M., Love, L.A.: Chaparral-associated hepatotoxicity. Arch. Intern. Med. 1997; 157: 913–919

    CrossRef  CAS  PubMed  Google Scholar 

  107. Skurnik, Y.D., Tchemiak, A., Edlan, K., Sthoeger, Z.: Ticlopidine-induced cholestatic hepatitis. Ann. Pharmacother. 2003; 37: 371–375

    CrossRef  PubMed  Google Scholar 

  108. Stickel, F., Pöschl, G., Seitz, H.K., Waldherr, R., Hahn, E.G., Schuppan, D.: Acute hepatitis induced by Greater Celandine (Chelidonium majus). Scand. J. Gastroenterol. 2003; 38: 565–568

    CAS  PubMed  Google Scholar 

  109. Stickel, F., Egerer, G., Seitz, K.H.: Hepatotoxicity of botanicals. Public Health Nutrit. 2000; 3: 113–124

    CAS  Google Scholar 

  110. Stoschus, B., Meybehm, M., Spengler, U., Scheurlen, C., Sauerbruch, T.: Cholestasis associated with mesalazine therapy in a patient with Crohn’s disease. J. Hepatol. 1997; 26: 425–428

    CrossRef  CAS  PubMed  Google Scholar 

  111. Tabak, F., Ozaras, R., Erzin, Y., Celik, A.F., Ozbay, G., Senturk, H.: Ornidazole-induced liver damage: report of three cases and review of the literature. Liver Internat. 2003; 23: 351–354

    Google Scholar 

  112. Talwakar, J.A., Soetikno, R.E., Carr-Locke, D.L., Berg, C.L.: Severe cholestasis related to itraconazole for the treatment of onychomycosis. Amer. J. Gastroenterol. 1999; 94: 3632–3633

    Google Scholar 

  113. ter Borg, E.J., Seldenrijk, C.A., Timmer, R.: Liver cirrhosis due to methotrexate in a patient with rheumatoid arthritis. Nederl. J. Med. 1996; 49: 244–246

    Google Scholar 

  114. Terpstra, O. T., ten Kate, F.J.W., van Urk, H.: Long-term survival after resection of a hepatocellular carcinoma with lymph node metastasis and discontinuation of oral contraceptives. Amer. J. Gastroenterol. 1984; 79: 474–478

    CAS  Google Scholar 

  115. Teschke, R.: Drug-induced liver diseases. Z. Gastroenterol. 2002; 40: 305–326

    CrossRef  CAS  PubMed  Google Scholar 

  116. Teschke, R.: Kava, kavapyrones and toxic liver injury. Z. Gastroenterol. 2003; 41: 395–404

    CAS  PubMed  Google Scholar 

  117. Thevenot, T., Mathurin, P., Martinez, F., Moussalli, J., Poynard, T., Opolon, P., Chosidow, O.: Acute hepatitis during hypersensitivity syndrome due to midecamycin. Europ. J. Gastroenterol. Hepatol. 1997; 9: 1249–1250

    CAS  Google Scholar 

  118. Trak-Smayra, V., Cazals-Hatem, D., Asselah, T., Duchatelle, V., Degott, C.: Prolonged cholestasis and ductopenia associated with tenoxicam (case report). J. Hepatol. 2003; 39: 125–128

    CrossRef  CAS  PubMed  Google Scholar 

  119. Treuner, J., Niethammer, D., Flach, A., Fischbach, H., Schenck, W.: Hepatozelluläres Karzinom nach Oxymetholonbehandlung. Med. Welt 1980; 31: 952–955

    CAS  PubMed  Google Scholar 

  120. Vale, J.A., Proudfoot, A.T.: Paracetamol (acetaminophen) poisoning. Lancet 1995; 346: 547–552

    CrossRef  CAS  PubMed  Google Scholar 

  121. Valla, D., Le, M.G., Poynard, T., Zucman, N., Rueff, B., Benhamou, J.-P.: Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study. Gastroenterology 1986; 90: 807–811

    CAS  PubMed  Google Scholar 

  122. van Outryve, S., Schrijvers, D., van den Brande, J., Wilmes, P., Bogers, J., van Marck, E., Vermorken, J.B.: Methotrexate-associated liver toxicity in a patient with breast cancer: case report and literature review. Netherl. J. Med. 2002; 60: 216–222

    Google Scholar 

  123. Van Steenbergen, W., Peeters, P., de Bondt, J., Staessen, D., Büscher, H., Laporta, T., Roskams, T., Desmet, V.: Nimesulide-induced acute hepatitis: evidence from six cases. J. Hepatol. 1998; 29: 135–141

    PubMed  Google Scholar 

  124. Vasudeva, R., Woods, B.: Isoniazid-related hepatitis. Dig. Dis. 1997; 15: 357–367

    CAS  PubMed  Google Scholar 

  125. Wanless, I.R., Mawdsley, C., Adams, R.: On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985; 5: 1194–1200

    CAS  PubMed  Google Scholar 

  126. Williams, K.V., Nayak, S., Becker, D., Reyes, J., Burmeister, L.A.: Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned? J. Clin. Endocrin. Metabol. 1997; 82: 1727–1733

    CAS  Google Scholar 

  127. Willmore, L.J., Triggs, W.J., Pellock, J.M.: Valproate toxicity: riskscreening strategies. J. Child. Neurol. 1991; 6: 3–6

    CAS  PubMed  Google Scholar 

  128. Yao, F., Behling, C.A., Saab, S., Li, S., Hart, M., Lyche, K.D.: Trimethoprim-sulfamethoxazole-induced vanishing-bile duct syndrome. Amer. J. Gastroenterol. 1997; 92: 167–169

    CAS  Google Scholar 

  129. Zachariae, H., Kragballe, K., Sogaard, H.: Methotrexate induced cirrhosis: studies including serial liver biopsies during continued treatment. Brit. J. Dermatol. 1980; 102: 407–412

    CAS  Google Scholar 

  130. Zafrani, E.S., Pinaudeau, Y., Dhumeaux, D.: Drug-induced vascular lesions of the liver. Arch. Intern. Med. 1983; 143: 495–502

    CrossRef  CAS  PubMed  Google Scholar 

  131. Zala, G., Schmidt, M., Bühler, H.: Fulminant hepatitis caused by disulfiram. Dtsch. Med. Wschr. 1993; 118: 1355–1360

    CAS  PubMed  Google Scholar 

  132. Zimmermann, H.J.: Drug-induced disease: an overview. Semin. Liver Dis. 1981; 1: 93–103

    Google Scholar 

  133. Zimpfer, A., Propst, G., Mikuz, G., Vogel, W., Terracciano, L., Stadlmann, S.: Ciprofloxacin-induced acute liver injury: case report and review of literature. Virch. Arch. 2004; 444: 87–89

    Google Scholar 

  134. Zucker, S.D., Qin, X.F., Rouster, S.D., Yu, F., Green, R.M., Keshavan, P., Feinberg, J., Sherman, K.E.: Mechanism of indinavir-induced hyperbilirubinemia. Proc. Nat. Acad. Sci. USA 2001; 98: 12671–12676

    CrossRef  CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and Permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

(2006). Drug-induced liver damage. In: Hepatology Principles and Practice. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28977-1_29

Download citation

  • DOI: https://doi.org/10.1007/3-540-28977-1_29

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-28976-0

  • Online ISBN: 978-3-540-28977-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

search

Navigation